Related Experiment Videos
Urticaria, angioedema, and autoimmunity
1Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California, USA.
Clinics in Laboratory Medicine
|October 8, 1997
Summary
Autoimmunity is now understood to be a key factor in chronic urticaria and acquired C1-INH deficiency angioedema. Autoantibodies directly cause mast cell degranulation in chronic urticaria and C1-INH deficiency.
Area of Science:
- Immunology
- Pathophysiology
Background:
- The link between autoimmunity and swelling disorders like chronic urticaria and angioedema was previously unclear.
- Autoimmune mechanisms are increasingly recognized in the pathogenesis of these conditions.
Purpose of the Study:
- To elucidate the role of autoantibodies in chronic urticaria and acquired C1-INH deficiency.
- To highlight the shift in understanding these conditions from allergic to autoimmune diseases.
Main Methods:
- Review of existing literature on autoantibodies in chronic urticaria and C1-INH deficiency.
- Analysis of autoantibody associations with mast cell degranulation and C1-INH deficiency.
Main Results:
- Autoantibodies against IgE and Fc epsilon RI directly induce mast cell degranulation in chronic urticaria.
- Most acquired C1-INH deficiency cases are linked to autoantibodies targeting C1-INH.
- Both conditions can co-occur with other autoimmune diseases.
Conclusions:
- Chronic urticaria is likely an autoimmune disease, not allergic.
- Autoantibodies are central to the pathogenesis of acquired C1-INH deficiency.
- Understanding autoantibody generation is crucial for future therapeutic advancements.